Background:Background: A recent clinical trial has demonstrated that patients with acute coronary syndromes (ACS) and the reduced function allele CYP2C19*2 (*2 allele), who are treated with thienopyridines, have an increased risk of adverse cardiac events with clopidogrel, but not with...

Background: Limited information exists on the best way to organise stroke rehabilitation after hospital discharge and the relative costs of such services. Objective: To review the evidence of the cost effectiveness of services that accelerate hospital discharge and provide home-based...

<Emphasis Type="Bold">Background: A recent clinical trial has demonstrated that patients with acute coronary syndromes (ACS) and the reduced function allele CYP2C19*2 (*2 allele), who are treated with thienopyridines, have an increased risk of adverse cardiac events with clopidogrel, but not with prasugrel. The...</emphasis>